TQPE administration with different doses (15 and 30 mg/kg/day) reversed the high level of insulin and HOMA-IR value compared with NAFLD mice (P < 0.001; Fig. 5). Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.